InvestorsHub Logo
Followers 2
Posts 213
Boards Moderated 0
Alias Born 03/10/2014

Re: None

Monday, 11/13/2017 10:16:20 AM

Monday, November 13, 2017 10:16:20 AM

Post# of 6378
Bio-Path Holdings (NASDAQ:BPTH) price target lowered to $1.50 (384% upside) from $4.50 by H.C. Wainwright citing delay in Phase 2 AML data on prexigebersen.

Surprise, Peter et al are about to miss another deadline!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News